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ABSTRACT
Objective: It is of primary importance to develop wound healing sealant that prevent bacteria contamination and 
growth. We propose to formulate poor platelets plasma material supplemented with a bactericidal plant extract, 
Ageratum conyzoides Linn. (Asteraceae). Aqueous extract of this plant is used as a bactericide.
Methodology: Platelet-poor plasma (PPP) containing less than 10,000 platelets per μL were used for all 
experimentations. Physiological serum (NaCl 0.9%) had served to prepare calcium chloride (CaCl ) solutions at 2
2M, 4M, 6M, 8M and 10M. Clauss fibrinogen assays were done to determine fibrinogen concentrations in each 
plasma pocket. Clotting times were measured following the addition of the appropriate calcium chloride 
concentration to the plasma. Plant extract at a concentration of 250 mg/mL in physiological serum was also added 
to the plasma and followed by the clotting times measured.
Results: Clauss fibrinogen assays reflected a global satisfactory fibrinogen concentration. Overall profile of the 
evolution of clotting time vs calcium concentrations adopts a curve form and the shortest clotting times are those 
obtained with 4M calcium concentration. However, the presence of extract deeply disturbed clotting process, as 
clotting times were extremely elongated.
Conclusion: Our objective was difficult to achieve because of the thrombin inhibitory side effects of the extract 
which were added to antithrombin III inhibitory effects in presence of excess calcium.
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Formation d'un Biomatériau de Fibrine par Apport Exogène de 
Calcium et Supplémentation par un Extrait Bactéricide de la plante 
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RÉSUMÉ 
Objectif: Il est d'une importance capitale de développer des pansements cicatrisants qui empêchent la 
contamination et la prolifération bactérienne. Nous nous proposons de formuler un biomatériau cicatrisant de 
fibrine à base de plasma pauvres en plaquettes et supplémenté d'un extrait aqueux de Ageratum conyzoides Linn. 
Méthodes: Du plasma pauvre en plaquettes contenant moins de 10 000 plaquettes par µL a été utilisé pour toutes 
les expérimentations. Le sérum physiologique (NaCl 0,9%) a servi à la préparation des différentes solutions de 
calcium aux concentrations de 2M, 4M, 6M, 8M et 10M. Le dosage du fibrinogène par les tests de Clauss a été 
effectué pour chaque poche de plasma. Les temps de gel ont été déterminés suite à l'addition du calcium à la 
concentration adéquate. L'extrait de plante à la concentration de 250 mg/mL dans du sérum physiologique a 
également été additionné au plasma suivi de la détermination des temps de gel.
Résultats: Les tests de Clauss mènent à des taux de fibrinogène moyens satisfaisants. Le profil global de 
l'évolution des temp de gel en fonction de la concentration en calcium adopte une forme hyperbolique et le temps 
le plus court est obtenu à 4M de calcium. La présence de l'extrait perturbe profondément la formation du gel 
puisque les temps de gel de ces derniers sont extrêmement rallongés.
Conclusion: Notre objectif a été difficile à atteindre à cause des effets secondaires inhibiteurs de l'extrait qui se 
sont ajoutés à ceux de l'antithrombin III en présence d'un excès de calcium.
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ORIGINAL ARTICLE
INTRODUCTION and contribute to chronic non-healing states (1). The 
Word Health Organization advocated that countries Fibrin sealant contains concentrated fibrinogen and 
should interact with traditional medicine in the aim to thrombin as its main active substrate and enzyme, and 
identify and explore aspects that provide safe and is usually mixed in the presence of calcium chloride, 
effective remedies for ailments of both microbial and which speeds up fibrin polymerization  (1). Ionic 
non-microbial origins  (7). The use of herbal conditions, numerous endogenous and exogenous 
preparations containing high doses of flavonoids for compounds, medications, as well as albumin, 
health maintenance has become very popular (8). fibronectin, lipoprotein(a), and other normal and 
Phytochemicals have exhibited potent activities pathological proteins present in plasma and injured 
while many researchers have used natural products to tissues, influence clot structure formation (2). One of 
act against bacterial resistance (9) and the the simplest methods for modifying fibrin structure is 
relationship between the structure of natural to vary the concentration of proteins, calcium, or salt 
compounds and their possible mechanism of action present during polymerization (3).
was established.Fibrin's high degree of tunability make it a 
Ageratum conyzoides Linn. (Asteraceae) is an versatile biomaterial that is used in a wide range of 
annual herb in the tropics and subtropics whose applications to facilitate wound repair, tissue 
extracts are known to possess pharmacological and engineering and regeneration, and biologics delivery 
biological activity (10). The mature plant is used for (3). Fibrin is an appealing drug delivery vehicle 
its hemostatic, and anti-inflammatory properties for because it can be injected where it gels in situ, it is 
the treatment of wounds in bacterial infections (11).naturally degraded and it  stimulates the body's own 
wound healing response  (4). Various extracts of the plant, including water 
and methanol have been shown to inhibit the growth Fibrin can also serve as a delivery vehicle for 
of Staphylococcus aureus, Bacillus subtilis, antimicrobial agents to prevent infection at the 
Escherichia coli, Pseudomonas aeruginosa  and wound site (3). Fibrin sealant can be used at the 
Helicobacter pylori (10). Aqueous extract of this specific targeted site such as chemotherapeutic 
plant is used as a bactericide (12).agents vehicle and antibiotics or hormones like the 
healing growth factors vehicle.  In these cases, Then, we propose to formulate poor platelets 
fibrinolysis governs the rate of drug or hormone plasma (PPP) material supplemented with the 
release from the fibrin vehicle (5) on the wound site. bactericide Ageratum conyzoides Linn. (Asteraceae) 
aqueous extract. During the formation of the hemostatic plug , 
adhesive glycoproteins from plasma become 
incorporated into the fibrin clot by covalent cross- MATERIALS AND METHODS
linking providing a scaffold for cell migration and 
Biological materials
proliferation (6). The major role of plasma 
Plasmacomplement present in various platelet biomaterials 
The plasma for the study was obtained from the derived from platelets-rich plasma in inactivating 
National Center of Blood Transfusion (Centre gram-negative E. coli, Klebsiella pneumonia, and 
National de Transfusion Sanguine - CNTS). After Pseudomonas aeruginosa was demonstrated (1).
different stages and types of control and individual However, working with poor platelets plasma 
donor plasma obtained, the National Center of Blood (PPP), means working in absence of platelets, 
Transfusion (Centre National de Transfusion allowing growth factors and plasma proteins 
Sanguine - CNTS) placed the plasma pockets at (fibrinogen, fibronectin) rich environment, without 
public disposal. They used CDPA-1 double blood bag cellular biomaterials conservation troubles and 
to supply citrated plasma.difficulties (cryoprecipitation, limit of conservation 
All tests were conducted on healthy random time). Then, we propose to formulate poor platelets 
population samples. To achieve this experiment, plasma (PPP) material supplemented with a 
fifteen (15) platelet-poor plasma (PPP) pockets bactericidal plant extract to retrieve biological and 
containing less than 10,000 platelets per μL were biochemical wound healing properties of a platelet 
used.rich plasma (PRP).
Ethical approval was obtained from the Bacterial infections are a serious problem in 
Institutional Committee of the National Center of wound healing and they impair tissue regeneration 
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Blood Transfusion (Centre National de Transfusion Plant materials
Sanguine - CNTS). Ageratum conyzoides Linn.
The plant samples were collected in the beginning of 
Physiological serum solutions the raining period in May 2019 in Guerin kouka (GPS 
coordinates: 9.6896200; 0.6079700) situated in the 500 mL sodium chloride solution or physiological 
Kara region in Northern Togo. serum (NaCl 0.9%) bottles (Batch N°: 1801021) from 
DO-PHARMA were used. Calcium chloride (CaCl ) Vegetable sample was botanically authenticated by 2
(Batch N°: 07/240028) was purchased from VWR Dr Atakpama of the Department of Botanic as “E 
International and had served to prepare solutions at 2, 9°41'22.6”N 0°36'28.7” University of Lome from the 
4, 6, 8 and 10 molars when dissolved in physiological National Forest Inventory of Togo database (IFN 
serum (NaCl 0.9%). This sodium saline was used as it 2015). The fresh material was oven-dried at a 
is isotonic with the plasma. temperature not exceeding 37 °C for a week.
Clotting time measures Extraction
For clotting time measures, coagulometer START4 To prepare plant extracts, the method, although 
(Diagnostica Stago) was used. Plasma samples were greatly modified, was inspired from (Li et al., 2011). 
aliquoted at a volume of 990 μL, 890 μL or 800 µL The dried leaves of the plant finely cut (25g in 
and stored at -20°C for a week at the most. To start the weight) were extracted with distilled water (250 ml): 
clotting times assays, each aliquot was warmed at 3h at 50 °C ± 2 °C.  Thereafter, the extracts were 
37°C in a waterbath for 15 minutes, then 10 μL of the weighted and a certain amount of 95% ethanol was 
correspondent calcium chloride concentration were added. The final concentration of extracts solution 
added to the 990 μL plasma aliquots. 890 μL plasma was obtained by dilution to 80%. This extract solution 
aliquots were added with 100 μL of physiological was deposited overnight at RT (25 °C ± 2 °C) and 
serum followed by 10 μL of the correspondent centrifuged at 4000 rpm for 10 min. The mixture was 
calcium chloride concentration. 800 µL plasma filtered and the filtrate was dried. The clear residue 
aliquots were added with 100 µL of physiological was dissolved in a sodium saline solution at a 
serum or 100 µL of 250 mg/mL extract in concentration of 250 mg/mL and used for 
physiological serum. Both mixings were completed biochemical studies.
with 90 µL of physiological serum followed with 10 
µL of the  correspondent calcium chloride 
Statistical analysis
concentration. Just after calcium chloride addition, 
All clotting time results were analyzed by the Student the chronometer was instantaneously triggered and 
test (14). The  95%-confidence interval (95%-CI) for the mixture homogenized. The limiting clotting time 
the percentage change at every time point was imposed for our experimental method was 2 hours 
calculated. Statistical significance was assumed for (120 minutes or 7200 seconds). For each calcium 
p-value < 0.05.chloride concentration, clotting time measurements 
were done in triplicate. For each calcium chloride 
concentration, clotting time measurements were RESULTS
done in triplicate. We measured each sample clotting Clauss assays
time three times for repeatability of the method 
A number of methods are used to determine leading to a total of fifteen (15) or nine (9) assays for 
fibrinogen concentration in plasma, and the widely five (05) or three (03) samples instead of testing 
used method is the functional fibrinogen assay fifteen (15) or nine (09) donors' plasma samples.
according to Clauss (15).
Clauss fibrinogen assay
In Table I, sixty per cent (60%) of plasma pockets ® ®Fibri-Prest  Automate (Réf. 00613), STA -Owren- corresponding to 9/15 of donors, have fibrinogen 
Koller (Réf. 00360), Unicalibrator (Réf. 00625), concentration belongs to the recommended 
Coag Control N + P (Réf. 00621) were used to international interval. Others 40% fibrinogen 
determine fibrinogen concentration in each plasma concentration are not so far from the lower limit. 
pocket. Fibrinogen concentration was expressed in Considering all the donors are safe, these results 
g/L or mg/dL. All the tests were done in triplicate and reflect a global satisfactory fibrinogen concentration.
the results were expressed as mean. 
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Clotting time measures When dilution attempted 80%, clotting times re-
increased. This was certainly due to fibrinogen In a previous work (14), we established an approved 
concentration lowering with dilution. However, the statistical method which is very helpful to determine 
lowerest clotting time was obtained at 4M calcium mean clotting times to obtain plasma fibrin sealant by 
concentration (11±4.15 minutes) and stayed lower only adding CaCl . In this experiment, we use the 2
than clotting time of not diluted plasma (13±1.57 same method to determine not diluted plasma, 
minutes). physiological serum diluted and extract added to 
plasma, fibrin clotting times. The previous established and approved statistical 
method (14) was also used to determine plant extracts All mean clotting times obtained for not diluted 
diluted (Table III) plasma mean clotting times.plasma and physiological serum diluted plasma are 
presented in Table II and represented in Figure 1. These results could not be statistically interpreted 
since clotting time >7200 seconds are not taken into 
account or are considered as no clotting. We obtained 
Clotting time mean variation after plasma dilution 
only one tc value at 2M calcium and no one at 4M 
(9/10th) with physiological serum is above 0.5; all 
calcium. Then they are not statistically 
clotting times from 2M to 8M calcium concentrations 
representative. Overall observation is that presence 
were divided by 2 when plasma was diluted at 90%. 
of extract deeply disturbs clotting process as we 
Figure 1 shows overall profile of the evolution of obtained no gelation at 6M, 8M and 10M. 
clotting time vs calcium concentrations adopts a 
At 2M calcium, not diluted plasma had a clotting time 
curve form. The shortest clotting times in the two 
value of 22 ± 3.81 minutes; physiological serum 
cases (not diluted and diluted plasma) are those 
diluted plasma (9/10) had a clotting time value of 11 ± 
obtained with 4M calcium concentration mixing with 
0.68 minutes and 250 mg extract diluted plasma had a 
plasma at 37°C. We have already shown that no 
clotting time value of 65 ± 12.56 minutes.
gelation occurred at 0M and 10M.
(2;6) is the recommended international interval for plasma
fibrinogen concentration.


















4 M 13±1,57 6 ±3,64
6 M 19 ±6,53 13 ±2,13
8 M 35 ±29,3 17 ±9
10 M >120 >120
Table 2: Clotting times of not diluted (990µL plasma) and diluted
plasma (890µL plasma) vs chloride calcium concentrations
Table 1: Clauss estimation of mean fibrinogen concentration in
the fifteen donors' pockets
Donors Blood group [Fg] mg/mL Є [2 ; 6] g/L
1 O- 1,77 No
2 O- 2,6 Yes
















7 A+  2,1  Yes
8 AB+  1,8  No











12 O+ 2,77 Yes
13 A+ 2,23 Yes
14 O+ 2,07 Yes
15 A+ 2,17 Yes
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DISCUSSION would not be systematically attributed to pathologic 
donors or dysfibrinogenemia cases. Then, all given Table 1 shows Clauss estimation of mean fibrinogen 
results were accepted.concentration in the fifteen donors' plasma pockets. A 
first analysis leads to sixty per cent (60%) of plasma Gelation dynamics induced by polymer 
pockets, corresponding to 9/15 of donors, who have solutions and crosslinkers have been studied for a 
f ibrinogen concentrat ion belongs to the long time. Most studies were conducted under mixing 
recommended international interval. Referring to our or agitation such as by stirring the solution to form an 
previous work (14), the third comprehensive way to isotropic gel,  since the gelation occurs 
explain variable clotting times obtained, was the homogeneously in the reaction system (16). In this 
possible high-hematocrit collected blood leading to study, experimental clotting times were noted when 
excessive citrate concentration, resulting in the movement of the ball stirring the sample solution 
elongated clotting time (meaning weak fibrinogen stopped.
concentration). According to this, the 40% of A multitude of parameters influence fibrin 
fibrinogen concentration which do not belong to the polymerization rates and resulting fiber structure 
recommended international interval but are very near including ionic strength, protein and zymogen 
to 2 mg/mL, the lower limit fibrinogen concentration, concentrations, calcium concentration, and pH (17). 
Calcium concentration
(CaCl2) (M)
2M 4M 6M 8M











































































Table 3: Clotting time measures of plant extracts diluted plasma
Figure 1: Clotting times of not diluted and diluted plasma vs chloride calcium concentrations
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There are correlations between gel time and final clot proteins, cell wall and efflux pumps. The 
structure, but the complete network is generally not antimicrobial mechanism of terpenes is closely 
established at the gel point, with new fibers and associated with their lipophilic features. 
branchpoints still being established afterward (2). Monoterpenes impact on the structures of the 
This phenomenon is explained by the fact that membrane, altering the topology of its proteins and 
thrombin is a processive enzyme. making disturbances across the respiration chain (9). 
Commonly, Gram-positive bacteria are more sensible In our previous work (14), three comprehensive 
to terpenes than Gram-negative ones. ways of plasma clotting time by adding exclusively 
exogenous calcium were identified. Among them, We also have identified the presence of 
interaction of calcium with citrate in citrated plasma stigmasterol, an analgesic (21), a triterpenoid and 
leading to activation of prothrombin to thrombin phylloquinol which is known as vitamin K1 required 
th(16). In the present work, 9/10  dilution of plasma for prothrombin formation. Three chromenes 
corresponds to less citrate needing calcium structures were also identified (20). The length of the 
interaction, then quicker activation of prothrombin to hydrocarbon chain connected to the hydroxyl group 
thrombin was observed. This resulted in shorter (aricjournal.biomedcentral.com) of various terpene 
clotting times (Table 2). We could hardly suppose that alcohols, plays an important role in antibacterial and 
sodium monovalent cations of sodium chloride cell membrane disrupting activity (9).Essential oil of 
present in physiological serum also interact with Ageratum conyzoides Linn. was found to have a 
citrate like calcium divalent cations. significant anti-inflammatory activity (12).
Based on their chemical structures, plant Biochemically wound healing process is 
components can be classified into alkaloids, sulfur- promoted by active agents that compose aqueous and 
containing compounds, terpenoids and polyphenols or alcohol herbal extracts and those components act 
(9). The largest and best known group among the synergistically. High water levels during gel 
polyphenolic compounds are flavonoids –(18). In a formulation (fibrin sealants are gels) can increase the 
previous work, we have demonstrated that Ageratum penetration of antibacterial compounds that diffuse 
conyzoides Linn. aqueous leaves extract (50°C – 3H), into the test media (21).
the extract we used in this study, contained several For this study, we first made antibacterial tests 
types of flavonoids (19). on wounds microbial pathogens and the efficacity 
Plant-derived compounds have displayed more was dose-dependent. Then, the concentration of 250 
potential applications in combating bacterial mg/mL of diluted extract in physiological serum was 
infections (9). The antibacterial activity of flavonoids choose for its efficacity on inhibiting wounds 
has a positive correlation with their ability to rigidify microbial pathogens activity.
the E. coli membrane (9). Flavonoids contained in Instead of all these supposed and confirmed 
Ageratum conyzoides Linn. show antibacterial an t ibac ter ia l  and  hea l thy  proper t ies  of  
activity; this could be related to their  ability to form phytochemicals contained in our extract, clotting 
complex connections with extracellular, soluble times profile has changed in presence of additional 
proteins, and bacterial cell walls (20). extract. The best and shortest clotting time obtained 
This extract contains proanthocyanidins and on extract diluted plasma, although prolonged, was 
their monomers catechins (19). The catechin gallates 65±12.56 minutes at 2M (20 mM final concentration) 
such as epigallocatechin gallate (EGCG) are another calcium. Comparing to not diluted plasma clotting 
group of phenolic compounds that provide health time at the same calcium concentration (CT=22±3.81 
benefits and also exhibited potent antimicrobial minutes) and to the lowerest clotting time obtained at 
activity against resistant pathogens (9). Tannins the same plasma dilution (CT=11±4.15 minutes), 
cause antimicrobial action by precipitating microbial clotting time of extract added plasma, is respectively 
proteins. The potency depends on their concentration 3 folds and six folds longer. Phytochemicals present 
in the plants (20). in the extract clearly possess thrombin inhibitory 
properties.Almost 50% of triterpenes were identified in our 
used extract (19) and terpenes or isoprenoids are The interest in enzyme inhibitors obtained from 
considered as the most diverse family of natural plants began in the 1940s (22). Bijak et al. (23) 
products (9). As antimicrobial molecules, terpenes showed that plant extracts at concentrations of 5 and 
have an effect on cytoplasm coagulation, membranes 50 μg / mL prolonged clotting time (APTT, PT, TT) 
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and decreased the maximal velocity of fibrin However, as we noted earlier, the clotting times 
polymerization in human plasma. Similar effects of profile when plant extract was added changed and at 
plants of Asteraceae and Rosaceae families are 4M calcium, among nine (9) samples only three (3) 
demonstrated by Pawlaczyk et al (24), who showed samples gelified, which are not statistically reliable. 
that the extracts from 17 plants of Asteraceae and For higher calcium concentrations (6M and 8M), no 
Rosaceae families prolonged APTT and PT of human gelation occurred. We then hypothesize that those 
plasma, when the concentrations of extracts were (0.1 phytochemicals probably not potentiate calcium 
– 12.5 mg/mL). It is well noting that Ageratum effect on antithrombin III but they rather have an 
conyzoides Linn. belongs to Asteraceae family and additional effect on inhibition of thrombin by 
thrombin, belonging to the family of serine proteases, antithrombin III in presence of excess calcium 
plays an incontestable role in the blood coagulation leading to elongation of the clotting time (14). Then, 
process (18). the co-presence of high calcium concentration and 
our extract phytochemicals lead to a serious Polyhydroxyflavones, oligohydroxy and 
inhibition of thrombin resulting in no gelation during oligomethoxyflavones, flavanones, flavonols and 
the 7200 seconds experimentation. methoxyflavones are all present in our extract (19). 
Though all their structures were not yet identified, on Wound dressings displaying antimicrobial 
average 45% of molecules in this extract are activity started to be produced in order to surpass skin 
polyhydroxyflavones. Chemically, we know that contamination and subsequent infections (27). 
polyphenols action is in part due to their hydroxyl Antimicrobial agents incorporated are antibiotics, 
group linked protein, preventing enzymatic action. nanoparticles and natural products.
According to Liu and al. (8), eleven flavonoids were 
shown to produce dose-dependently inhibitory 
CONCLUSION
activities on thrombin. In fact, polyphenols interact 
This study is an original one which aimed to create a with platelets proteins and inhibit thrombin. Almost 
new fibrin sealant biomaterial combining the 50% of triterpenes were identified in our extract (19) 
properties of a fibrin gel with antibacterial and and we know terpenes also belong to enzymes 
analgesic properties of phytochemicals contained in inhibitors. Our extract contained proanthocyanidins 
an aqueous Ageratum Conyzoides Linn. leaves and their monomers catechins (19). Flavonoids 
extract at a bactericide concentration. Our objective which inhibit thrombin amidolytic activity belong to 
was difficult to achieve because of the thrombin flavanols, flavonols anthocyanins aglycones with 
inhibitory side effects of the extracts which were –OH substituents at the position of R1 and R2 in the 
added to antithrombin inhibitory effects in presence B-ring) –(18).
of excess calcium; however, we do not fail at all since 
In addition, Li et al. had demonstrated the 
at 2 M calcium concentration a clotting time was 
binding positions of six flavonoid compounds were 
obtained.
alike with argatroban (25). It is worth mentioning that 
We hardly supposed that our difficulties to all of them located in the activity center and had 
obtain gelation provided from the stirring method interaction with the residue HIS57 or SER195, which 
used. In fact, when the solution (plasma + extract + indicated that these compounds likely had thrombin 
calcium) are just mixed and homogenized, a gel inhibitory activity (25). Serine proteinases activity is 
occurred in few minutes. Evidently, they are weak blocked through a tight binding of the enzyme active 
gels. Some studies demonstrated a reversible site and the inhibitor, resulting in a complex resistant 
inhibitory effect of flavonoids on serine proteases. to proteolysis (22). Human thrombin preference for 
Then we have to make deeper studies or change small, planar flavonoids confirms the structural 
clotting time determination method to achieve this features of the restricted catalytic pocket of the 
novel biomaterial.enzyme (26). Clustering the docking conformations 
of thrombin-phenolic acid complexes, the result 
showed that their optimal conformation was not CONFLICT OF INTEREST 
present in the activity center, meaning that phenolic The authors have not declared any conflict of 
acid compounds could bind with other places of the interests.
enzyme (25).
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